WeVote
Log In

Bill

Bill

S 9272

Relates to expanding opioid overdose prevention measures in certain settings

2025 Regular Session Introduced by Nathalia Fernández and 1 co-sponsor

Expands on-site access to opioid antagonists (naloxone) in schools and public libraries, with trained personnel, oversight, and voluntary participation to enable emergency administ

RETURNED TO SENATE
0
WeVote Research Nonpartisan
Bill Summary · S 9272

Summary of Bill S. 9272 (2025-2026) – New York

Main purpose and intent

  • The bill expands opioid overdose prevention measures in selected public settings. Specifically, it requires certain entities to provide on-site access to opioid antagonists (e.g., naloxone) and to establish a framework for administering them in emergencies, with attention to trained personnel and compliance with health-record-keeping and oversight requirements.

Key provisions and changes

1) On-site opioid antagonists
- Required recipients: school districts, public libraries, Boards of Cooperative Educational Services (BOCES), county vocational education and extension boards, charter schools, and non-public elementary and secondary schools.
- Obligation: to provide and maintain on-site access to opioid antagonists in quantities and types deemed adequate by the state Education Department (in consultation with the Department of Health). This access is intended for use during emergencies by:
- students
- individuals on library premises
- staff suspected of having an opioid overdose
- Location: on-site in each instructional school facility or library.

2) Training and administration
- Recipients may elect to participate as an opioid antagonist recipient.
- Any person employed by an entity that has elected to participate may administer an opioid antagonist in an emergency.
- Training: individuals authorized to administer must have been trained by a program approved under Public Health Law § 3399 (3,309 in the Public Health Law; “section 33309” in the bill’s numbering).
- Compliance: entities that participate and have trained staff must comply with the Public Health Law requirements for administration, including appropriate clinical oversight, record-keeping, and reporting.

3) Voluntary participation and safeguards
- Participation is voluntary; no person is mandatory to participate in the program.
- Those who participate must adhere to the health law’s oversight and documentation standards.

4) Effective date
- The act takes effect immediately upon enactment.

Who/what would be affected

  • Entities:
    • Public school districts
    • Public libraries
    • BOCES
    • County vocational education and extension boards
    • Public and non-public charter schools
    • Non-public elementary and secondary schools
  • People:
    • Students
    • School/library staff
    • Any individual on library premises who may be experiencing an overdose (as a potential recipient of treatment)
  • Staff and administrators:
    • Those trained to administer opioid antagonists
    • Those responsible for inventory, storage, and record-keeping

Procedural and timeline aspects

  • Legislative path:
    • Introduced in Senate, referred to the Committee on Alcoholism and Substance Use Disorders
    • Subsequent committee movements and floor actions culminated in passage in the Senate and Assembly in June 2026, with the bill moving toward final steps (e.g., potential enrollment or signature by the Governor, depending on the session process).
  • Compliance timeline:
    • Once in effect, participating entities must set up on-site access and ensure trained personnel are in place; ongoing compliance with health department oversight is required.

Potential impact

  • Public health and overdose response:
    • Expands immediate access to opioid antagonists in schools and libraries, potentially reducing fatal overdose outcomes by enabling rapid response.
  • Training and oversight:
    • Establishes a standardized framework for training and reporting, aligning with state health department guidance.
  • Autonomy and safety:
    • Keeps participation voluntary, balancing public health goals with individual and institutional autonomy.
  • Resource considerations:
    • Entities will need to allocate resources for stocking antagonists and training staff, consistent with recommended quantities and types.

If you’d like, I can provide a point-by-point comparison with current law (pre-2016 amendments) or summarize potential fiscal implications based on typical costs for naloxone stocking and training.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.